Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.3.5.1 extracted from

  • Cervera, A.M.; Bayley, J.P.; Devilee, P.; McCreath, K.J.
    Inhibition of succinate dehydrogenase dysregulates histone modifications in mammalian cells (2009), Mol. Cancer, 8, 89.
    View publication on PubMedView publication on EuropePMC
Search for more literature for 1.3.5.1

Application

Application Comment Organism
medicine mutations in the genes encoding succinate dehydrogenase are associated with hereditary predisposition to pheochromocytoma and paraganglioma. The results support the notion that loss of mitochondrial function alters epigenetic processes and might provide a signature methylation mark for paraganglioma Homo sapiens

Inhibitors

Inhibitors Comment Organism Structure
2-Thenoyltrifluoroacetone
-
 Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
HEK-293 cell
-
 Homo sapiens
-

Synonyms

Synonyms Comment Organism
succinate dehydrogenase
-
 Homo sapiens

General Information

General Information Comment Organism
physiological function using pharmacological and siRNA methodologies it is shown that increased methylation of histone H3 is a general consequence of SDH loss-of-function in cultured mammalian cells and can be reversed by overexpression of the JMJD3 histone demethylase. ChIP analysis reveals that the core promoter of IGFBP7, which encodes a secreted protein upregulated after loss of SDHB, shows decreased occupancy by H3K27me3 (histone 3 methylated on residue K27) in the absence of SDH Homo sapiens